Dystonia Genotype-Phenotype Correlation
Part of paid clinical trials in Dallas, Texas.
- Sponsor
- University of Texas Southwestern Medical Center
- Study ID
- NCT03428009
- Status
- Recruiting
Conditions
- Dystonia
- Dystonia 10
- Dystonia 11
- Dystonia 12
- Dystonia 19
- Dystonia 20
- Dystonia 5
- Dystonia 6
- Dystonia 8
- Dystonia 9
- Dystonia Disorder
- Dystonia Lenticularis
- Dystonia of Head
- Dystonia, Diurnal
- Dystonia, Familial
- Dystonia, Focal
- Dystonia, Paroxysmal
- Dystonia, Primary
- Dystonia, Secondary
- Dystonia; Idiopathic
- Dystonia; Orofacial
- Dystonias, Sporadic
Eligibility Criteria
- Sex
- ALL
- Age
- 11 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Magnetic Resonance Imaging — OTHERStudy interventions are minimal risk.
Study Details
The purpose of this study is to (1) investigate the effect of known dystonia-causing mutations on brain structure and function, to (2) identify structural brain changes that differ between clinical phenotypes of dystonia, and to (3) collect DNA, detailed family history, and clinical phenotypes from patients with idiopathic dystonia with the goal of identifying new dystonia-related genes. Investigators will be recruiting both healthy control subjects and subjects with any form of dystonia. For this study there will be a maximum of two study visit involving a clinical assessment, collection of medical and family history, task training session, an MRI using the learned tasks, and finally a blood draw for genetic analysis. In total, these visits will take 3-5 hours. If the dystonia subjects receive botulinum toxin injections for treatment, the participants and their matched controls will be asked to come for a second visit.
Key Dates
- Start date
- Mar 1, 2018
- Status verified
- Jun 2025
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 200 participants (estimated)
Arms
- Arm: Dystonia groupBoth groups will have blood drawn, undergo clinical assessments, the collection of medical and family history, and an Magnetic Resonance Imaging. This is an observational study and there is no intervention.
- Arm: Control GroupBoth groups will have blood drawn, undergo clinical assessments, the collection of medical and family history, and an Magnetic Resonance Imaging. This is an observational study and there is no intervention.
Primary Outcome Measure
Structural or functional imaging of dystonia and control groups [ Time Frame: 3-5 hours at each study visit ]
Central Contacts
- Alyssa Boudreau214-456-2106
- Jeff Waugh, MD, PhD214-867-6906
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | Jeff Waugh, MD/PhD |
Find similar trials in Dallas, TX
Related Studies
- Abbott DBS Post-Market Study of Outcomes for Indications Over TimeRecruiting · Abbott Medical Devices · Tucson, Arizona
- A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated DystoniaPHASE2 · Recruiting · Vima Therapeutics · Birmingham, Alabama
- Physiological Brain Atlas DevelopmentRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Deep Brain Stimulation Surgery for Movement DisordersRecruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland